Overview
Tirzepatide was studied as LY3298176. The original work by Coskun and colleagues describes dual GIP and GLP-1 receptor activity and the progression from discovery to early clinical proof of concept.
Identity & classification
- NAME
- Tirzepatide
- RESEARCH CODE
- LY3298176
- RESEARCH CATEGORY
- METABOLIC RESEARCH
- MOLECULAR CLASS
- Dual-receptor peptide agonist
- KEY DISTINCTION
- Dual-receptor activity; distinguish study material from an individual sample
Reading the evidence
Read receptor studies with their models, endpoints and development stage in view. A publication provides molecular context; it does not test the identity, content or purity of an unrelated individual sample.